Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)

China flag China · Delayed Price · Currency is CNY
33.35
-0.53 (-1.56%)
Mar 9, 2026, 4:00 PM EDT
34.64%
Market Cap 2.99B
Revenue (ttm) 439.57M
Net Income (ttm) 75.96M
Shares Out 89.68M
EPS (ttm) 0.84
PE Ratio 39.67
Forward PE n/a
Dividend 0.09 (0.27%)
Ex-Dividend Date Jun 12, 2025
Volume 1,138,200
Average Volume 1,034,551
Open 33.64
Previous Close 33.88
Day's Range 33.07 - 34.00
52-Week Range 20.56 - 39.28
Beta 0.54
RSI 42.72
Earnings Date Apr 23, 2026

About SHE:301258

Suzhou Fushilai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and health care raw materials in China and internationally. The company offers lipoic acid products comprising granular alpha lipoic acid, R-lipoic acid, r-lipoic acid tromethamine salt, and 6,8-dichlorooctanoic acid ethyl ester; l-carnosine; phosphatidylcholine products, which include glycerylphosphatidylcholine; and erelcoxib API, a nonst... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 524
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301258
Full Company Profile

Financial Performance

In 2024, SHE:301258's revenue was 429.47 million, a decrease of -12.23% compared to the previous year's 489.29 million. Earnings were 16.41 million, a decrease of -85.38%.

Financial Statements

News

There is no news available yet.